TY - BOOK
T1 - Advances in diagnostic imaging
T2 - The value of contrast-enhanced ultrasound for liver
AU - Bolondi, Luigi
AU - Lencioni, Riccardo
AU - Della Pina, Clotilde
AU - Crocetti, Laura
AU - Cioni, Dania
AU - Peterweskott, Hans
AU - Correas, Jean Michel
AU - Khairoune, Ahmed
AU - Vallet-Pichard, Anais
AU - Pol, Stanislas
AU - Hélénon, Olivier
PY - 2006
Y1 - 2006
N2 - In recent years, the imaging-based diagnosis of mass liver lesions has become increasingly complex due to the number and morphological variability of lesions that modern imaging techniques are currently able to display. If the sensitivity in detection has greatly increased, characterisation has remained difficult and represents a critical challenge for the clinician. The availability of blood-pool contrast agents for ultrasound (US), in particular second-generation US contrast agents based on perfluorocarbon- or sulfur-hexafluoride-filled microbubbles, and the development of contrast-specific software and technologies have opened up new perspectives both for the immediate characterisation of any mass lesion detected in the liver and for increasing the sensitivity of US in the detection of liver metastases. Taking into account the great impact of this new technology on clinical practice, the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) organised, in January 2004, in Rotterdam, a consensus meeting of experts in order to develop guidelines for the use of US contrast agents in the diagnosis of liver diseases . These guidelines, as well as discussions of further advances in the clinical application of contrast-enhanced harmonic US are presented in this book by an internationally renowned group of experts. The book represents provides an important starting point for clinical implementation of this new diagnostic procedure.
AB - In recent years, the imaging-based diagnosis of mass liver lesions has become increasingly complex due to the number and morphological variability of lesions that modern imaging techniques are currently able to display. If the sensitivity in detection has greatly increased, characterisation has remained difficult and represents a critical challenge for the clinician. The availability of blood-pool contrast agents for ultrasound (US), in particular second-generation US contrast agents based on perfluorocarbon- or sulfur-hexafluoride-filled microbubbles, and the development of contrast-specific software and technologies have opened up new perspectives both for the immediate characterisation of any mass lesion detected in the liver and for increasing the sensitivity of US in the detection of liver metastases. Taking into account the great impact of this new technology on clinical practice, the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) organised, in January 2004, in Rotterdam, a consensus meeting of experts in order to develop guidelines for the use of US contrast agents in the diagnosis of liver diseases . These guidelines, as well as discussions of further advances in the clinical application of contrast-enhanced harmonic US are presented in this book by an internationally renowned group of experts. The book represents provides an important starting point for clinical implementation of this new diagnostic procedure.
UR - http://www.scopus.com/inward/record.url?scp=84892248393&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84892248393&partnerID=8YFLogxK
U2 - 10.1007/88-470-0458-6
DO - 10.1007/88-470-0458-6
M3 - Book
AN - SCOPUS:84892248393
SN - 8847004578
SN - 9788847004573
BT - Advances in diagnostic imaging
PB - Springer Milan
ER -